Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Learn essential ways to get started in real estate investing, paving your path to financial independence. Begin your investment journey today.
23,306 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
A trio of megacaps—NVIDIA, Alphabet, and Amazon—has caught the eye of stocks wall street analysts as the era of AI fu...
OpenAI’s Sam Altman apologized for sloppy wording in announcing a Pentagon contract, pledging a revised release to em...
Manufacturing activity rose to a multi-year high in February, suggesting broad economic resilience even as Winter Sto...
As 2026 budget cycles unfold, investors are rethinking how the weapons that built army legacy translate into today’s ...
A major fund recently trimmed its Centrus Energy stake, sending ripples through the market. This article breaks down ...
As 2025 closes, KLX Energy Services faces a choppy energy market. This guide breaks down the Q4 2025 earnings landsca...
Bitcoin is showing notable strength with a 3.7% rise in a single session. This piece breaks down the catalysts behind...
Centuri Holdings ends 2025 with a booming backlog and falling debt, yet investors face a high bar to justify lofty va...
With megacap dominance fading, traders are rethinking how to beat without magnificent risk. Equal-weight strategies a...
Alphabet outpaced Amazon over the past decade in total returns, turning a $1,000 stake into roughly $7,759 vs Amazon’...
LoanDepot posted a larger first-quarter loss as market volatility and thinner gain-on-sale margins weighed on revenue...